References
- YANG X., CHEN H., ZHENG Y., QU S., WANG H., YI F.. Disease burden and long-term trends of urinary tract infections: A worldwide report. Front Public Health. 2022;10:888205.
- MEDINA M., CASTILLO-PINO E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172
- VADHAN J.D., THOPPIL J., VASQUEZ O., SUAREZ A., BARTELS B., MCDONALD S., et al. Primary infection site as a predictor of sepsis development in emergency department patients. J Emerg Med. 2024;67(2):e128–e37.
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55.
- CASSINI A., HÖGBERG L.D., PLACHOURAS D., QUATTROCCHI A., HOXHA A., SIMONSEN GS., et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.
- CARLOTTA N., NITIN M., DAVE B., BHASKAR KUMAR S. Gram negative bacteria related urinary tract infections: spectrum of antimicrobial resistance over 9 years in a University tertiary referral Hospital. Ther Adv Infect Dis. 2024;11:20499361241234513.
- HOLMES A.H., MOORE L.S., SUNDSFJORD A., STEINBAKK M., REGMI S., KARKEY A., et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–87.
- KRANZ J., BARTOLETTI R., BRUYÈRE F., CAI T., GEERLINGS S., KÖVES B., et al. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. Eur Urol. 2024;86(1):27–41.
- RAPHAEL E., ARGANTE L., CINCONZE E., NANNIZZI S., BELMONT C., MASTRANGELO C.F., et al. Incidence and recurrence of urinary tract infections caused by uropathogenic Escherichia coli: A retrospective cohort study. Res Rep Urol. 2024;16:253–64.
- DESSAU R.B., ANDERSEN C., COIA J., ELLERMANN-ERIKSEN S., GUBBELS S., JENSEN TG., et al. The increasing incidence and mortality of bacteremia in Denmark from 2010 to 2022: a population-based nationwide cohort study. Front Public Health. 2024;12:1502893
- LEDOCHOWSKI S., ABRAHAM P-S., JACOB X., DUMITRESCU O., LINA G., LEPAPE A., et al. Relevance of blood cultures in acute pyelonephritis in a single-center retrospective study. Internal and Emergency Medicine. 2015;10(5):607–12.
- COBURN B., MORRIS AM., TOMLINSON G., DETSKY A.S. Does this adult patient with suspected bacteremia require blood cultures? JAMA. 2012;308(5).
- VELASCO M., MARTÍNEZ J.A., MORENO-MARTÍNEZ A., HORCAJADA J.P., RUIZ J., BARRANCO M., et al. Epidemiological study of secondary bloodstream infections: The forgotten issue. J Infect Public Health. 2019;12(1):37–42.
- YAHAV D., ELIAKIM-RAZ N., LEIBOVICI L., PAUL M. Bloodstream infections in older patients. Virulence. 2016;7(3):341–52.
- ÁLVAREZ OTERO J., LAMAS FERREIRO J.L., SANJURJO RIVO A., MAROTO PINEIRO F., GONZALEZ GONZALEZ L., ENRIQUEZ DE SALAMANCA HOLZINGER I., et al. Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales. PLOS ONE. 2020;15(10):e0237365.
- SCHINAS G., SKINTZI K., DE LASTIC A.L., RODI M., GOGOS C., MOUZAKI A., et al. Patterns, Cost, and Immunological Response of MDR vs. Non MDR-Bacteremia: A Prospective Cohort Study. Pathogens. 2023;12(8).
- AKINOSOGLOU K., DAVOULOS C., DELASTIC A.L., KOLOSAKA M., NIAROU V., THEODORAKI S., et al. Managing hospitalized patients with bacterial infections: the price-to-pay upon site of infection. Rural Remote Health. 2022;22(2):6347.
- MEGGED O. Bacteremic vs nonbacteremic urinary tract infection in children. Am J Emerg Med. 2017;35(1):36–8.
- MADRAZO M., LÓPEZ-CRUZ I., PILES L., ARTERO S., ALBEROLA J., AGUILERA J.A., et al. Risk factors for bacteremia and Its clinical impact on complicated community-acquired urinary tract infection. Microorganisms [Internet]. 2023; 11(8).
- BROOKS D., SMITH A., YOUNG D., FULTON R., BOOTH M.G. Mortality in intensive care: The impact of bacteremia and the utility of systemic inflammatory response syndrome. American Journal of Infection Control. 2016;44(11):1291–5.
- HSU C.C., LIN P.C., CHEN K.T. The presence of bacteremia indicates higher inflammatory response and augments disease severity in adult patients with urinary tract infections. J Clin Med. 2022;11(14).
- MOSEVOLL K.A., SKREDE S., MARKUSSEN D.L., FANEBUST H.R., FLAATTEN H.K., AßMUS J., et al. Inflammatory mediator profiles differ in sepsis patients with and without bacteremia. Front Immunol. 2018;9:691.
- SANDBERG M., VANCAVAGE R., REFUGIA J.M., UNDERWOOD G., YE E., MARIE-COSTA C., et al. Post-operative urinary tract infections after radical cystectomy: incidence, pathogens, and risk factors. J Clin Med. 2024;13(22).
- FENELON H.T., HAWES S.E., KAPOOR H., SALM A.E., RADCLIFF J., RABINOWITZ P.M. Regional variation in urinary escherichia coli resistance among outpatients in Washington State, 2013–2019. Microorganisms. 2024;12(11).
- TAMMA P.D., AITKEN S.L., BONOMO R.A., MATHERS A.J., VAN DUIN D., CLANCY C.J. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clinical Infectious Diseases. 2023:ciad428.
- MICHAEL C.K., LIANOU D.T., TSILIPOUNIDAKI K., FLOROU Z., VASILEIOU N.G.C., MAVROGIANNI V.S., et al. Longitudinal study of antibiotic resistance of Staphylococci from cases of subclinical mastitis in sheep in Greece: Incidence and risk factors. Antibiotics [Internet]. 2023; 12(12).
- European Centre for Disease Prevention and Control and World Health Organization. Regional Office for Europe. Antimicrobial resistance surveillance in Europe 2023–2021 data. 2023. Available from:
https://iris.who.int/handle/10665/366822 . - KARAKOSTA P., VOURLI S., KOUSOULI E., MELETIS G., TYCHALA A., LOUKA C., et al. Multidrug-resistant organism bloodstream infection and hospital acquisition among inpatients in three tertiary Greek hospitals during the COVID-19 era. Eur J Clin Microbiol Infect Dis. 2024;43(6):1241–6.
- ONORATO L., ALLEGORICO E., MACERA M., MONARI C., MIGLIACCIO B., NASTA C., et al. Prevalence and impact of multidrug resistance in a cohort of patients admitted to emergency department for urinary tract-infections: The UTILY study, a prospective multicentre study. Eur J Intern Med. 2024.133:93–99
- SHAHSAVARI S, BAKHT M, SADEGHI H, RAHIMI S, MOVAHED F, CHEGINI V, et al. Effect of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in patients with urinary tract infection. Arch Razi Inst. 2024;79(1):92–101.
- TANDOGDU Z., KOVES B., RISTOVSKI S., BALCI M.B.C., RENNESUND K., GRAVAS S., et al. Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study. World J Urol. 2024;42(1):314.
- BONINE N.G., BERGER A., ALTINCATAL A., WANG R., BHAGNANI T., GILLARD P., et al. Impact of delayed appropriate antibiotic therapy on patient outcomes by antibiotic resistance status From Serious Gram-negative Bacterial Infections. The American Journal of the Medical Sciences. 2019;357(2):103–10.
- ZASOWSKI E.J., BASSETTI M., BLASI F., GOOSSENS H., RELLO J., SOTGIU G., et al. A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections. Chest. 2020;158(3):929–38.
- NIEDERMAN M.S. Clinical impact of antimicrobial resistance: Using new tools to answer old puestions. Chest. 2019;155(6):1088–9.
- SIVANANDY P., MANIRAJAN P., WEN QI O., TENG KHAI O., CHUN WEI O., WEI YING N., et al. A systematic review of efficacy and safety of newer drugs approved from 2016 to 2023 for the treatment of complicated urinary tract infections. Ann Med. 2024;56(1):2403724.
- ISHAK A., MAZONAKIS N., SPERNOVASILIS N., AKINOSOGLOU K., TSIOUTIS C. Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice. Journal of Antimicrobial Chemotherapy. 2025;80(1):1–17.
- GÓMEZ-ZORRILLA S., BECERRA-APARICIO F., SENDRA E., ZAMORANO L., GRAU I., PINTADO V., et al. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain. J Hosp Infect. 2024;151:173–85.
- RAPTI V., POULAKOU G., MOUSOULI A., KAKASIS A., PAGONI S., PECHLIVANIDOU E., et al. Assessment of de-escalation of empirical antimicrobial therapy in medical wards with recognized prevalence of multi-drug-resistant pathogens: A multicenter prospective cohort study in non-ICU patients with microbiologically documented infection. Antibiotics (Basel). 2024;13(9):812
- SABIH A., LESLIE S.W. Complicated urinary tract infections. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC.; 2025.
- STANGL F., WAGENLEHNER F., SCHNEIDEWIND L., KRANZ J. [Urosepsis: pathophysiology, diagnosis, and management-an update]. Urologie. 2024;63(6):543–50.
- TSUCHIYA T., TAITO K., OTA Y., MATSUNO S., YAMANAKA N., OKA M., et al. Risk factors for septic shock in older patients with urinary tract infection. Clin Exp Nephrol. 2024(3):368–375